Learn More
Medchemexpress LLC Binimetinib | 606143-89-9 | 1 ML

Supplier: Medchemexpress LLC HY1520210MM/1ML
Binimetinib (MEK162) is an oral and selective MEK1/2 inhibitor with an IC50 of 12 nM. It demonstrates antiproliferative activity against various human cancer cell lines, including those with KRAS and NRAS mutations, and reduces disease severity in animal models.
- Oral and selective MEK1/2 inhibitor.
- Potently inhibits MEK with an IC50 of 12 nM.
- Blocks basal ERK phosphorylation in HRAS mutant cell lines.
- Exhibits antiproliferative activity against various KRAS and NRAS mutant human cancer cell lines.
- Reduces disease severity in animal models.
- Demonstrates enhanced efficacy when combined with other agents in animal models.
- Shows significant tumor growth reduction when combined with BEZ235.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.